Results 131 to 140 of about 28,258 (264)

The 2022 Nobel Prize in Chemistry-sweet! [PDF]

open access: yesGlycobiology, 2023
Boyce M   +3 more
europepmc   +1 more source

Design, synthesis and activity evaluation of tetrahydroisoquinoline‐based programmed cell death ligand 1 inhibitors

open access: yesSmart Molecules, EarlyView.
Based on a 3D‐quantitative structure‐activity relationship pharmacophore model, structural optimization of Y6 yielded Y7f. Mechanistic studies revealed that Y7f acted as a programmed death receptor 1/programmed cell death ligand 1 (PD‐L1) interaction inhibitor by inducing PD‐L1 dimerization. Y7f restored T‐cell function.
Menglin Yu   +15 more
wiley   +1 more source

Why Did Treg and Immune Tolerance Win Nobel Prize This Year? [PDF]

open access: yesGenomics Proteomics Bioinformatics
Zheng 郑颂国 SG.
europepmc   +1 more source

The Allais Paradox and Upside/Downside Risk Preference: An Experimental Analysis With Probability Weighting and Chernoff Faces

open access: yesSouthern Economic Journal, EarlyView.
ABSTRACT The Allais Paradox is often attributed to the strong attraction of a certain option that avoids a downside risk, i.e., a small chance of a low payoff. In contrast, there is clear evidence from laboratory and field data that people are attracted to the upside risk of obtaining a relatively high payoff.
Irene Comeig, Charles Holt
wiley   +1 more source

Oxaziridines: Versatile Reagents in Modern Organic Synthesis

open access: yesThe Chemical Record, EarlyView.
Being capable of transferring an O atom and N‐group/atom, oxaziridines are considered multitasking agents. These are employed for diverse organic transformations, such as epoxidation of olefins, α‐ and γ‐hydroxylation/amination of carbonyl compounds, oxidation of sulfides, [3+2]cycloaddition with unsaturated systems.
Ajeet Chandra   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy